The following pages contain information relating to the capital increase of Elanix Biotechnologies AG. For regulatory reasons, access to this information is restricted. This information is intended solely for persons present in Germany.
These website pages and the information on it is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This website section does not constitute or form part of an offer of securities for sale or solicitation of an offer to purchase securities in the United States, Canada, Australia, Japan or in any other jurisdiction in which such offer may be restricted. The securities referred to on this website have not been, and will not be, registered under the US Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States, except on the basis of an applicable exemption from the registration requirements or in a transaction not subject to the registration requirements of the Securities Act. There will be no public offering of securities in the United States.